BMY is looking to turn its business around, banking on the strong uptake of new drugs. The recent spate of positive ...

Virtual reality has been a standout technology in the medical industry since the turn of the decade. From its use as a ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...